Genetic Variants Associated with von Willebrand Factor Levels in Healthy Men and Women Identified Using the HumanCVD BeadChip

We have used the gene‐centric Illumina HumanCVD BeadChip to identify common genetic determinants of Von Willebrand factor (vWF) levels in healthy men and women.

[1]  J. Deckers,et al.  Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease. , 2011, Blood.

[2]  Ming-Huei Chen,et al.  Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium , 2010, Circulation.

[3]  Tom R. Gaunt,et al.  Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. , 2009, American journal of human genetics.

[4]  P. Whincup,et al.  Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men , 2009, Journal of thrombosis and haemostasis : JTH.

[5]  Mark I. McCarthy,et al.  Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies , 2008, PloS one.

[6]  B. Jilma,et al.  Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes , 2008, Circulation.

[7]  Simon C Watkins,et al.  Sequences in Intron 51 of the von Willebrand Factor Gene Target Promoter Activation to a Subset of Lung Endothelial Cells in Transgenic Mice* , 2008, Journal of Biological Chemistry.

[8]  P. Schneider,et al.  Forensic STRs as potential disease markers: a study of VWA and von Willebrand's Disease. , 2007, Forensic science international. Genetics.

[9]  D. Lawlor,et al.  Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[10]  E. Cuppen Genotyping by Allele-Specific Amplification (KASPar). , 2007, CSH protocols.

[11]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[12]  D. Strachan,et al.  Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population , 2007, Circulation.

[13]  Paul Scheet,et al.  A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. , 2006, American journal of human genetics.

[14]  C. Power,et al.  Cohort profile: 1958 British birth cohort (National Child Development Study). , 2006, International journal of epidemiology.

[15]  J. Sadler,et al.  Binding of ADAMTS13 to von Willebrand Factor* , 2005, Journal of Biological Chemistry.

[16]  Michael Marmot,et al.  Cohort Profile: the Whitehall II study. , 2005, International journal of epidemiology.

[17]  P. Whincup,et al.  The British Regional Heart Study 1975-2004. , 2004, International journal of epidemiology.

[18]  D. Lawlor,et al.  Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study , 2003, Journal of epidemiology and community health.

[19]  J. Danesh,et al.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis. , 2002, European heart journal.

[20]  V. Kretschmer,et al.  Influence of ABO blood groups on primary hemostasis , 2001, Transfusion.

[21]  M. Kumari,et al.  Social determinants of von willebrand factor: the Whitehall II study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[22]  P. Harvey,et al.  A single nucleotide polymorphism at nucleotide −1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels , 2000, British journal of haematology.

[23]  G. Chatellier,et al.  Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes , 2000 .

[24]  G. Chatellier,et al.  Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. , 2000, Kidney international.

[25]  D. Economides,et al.  Variations in Coagulation Factors in Women: Effects of Age, Ethnicity, Menstrual Cycle and Combined Oral Contraceptive , 1999, Thrombosis and Haemostasis.

[26]  D. Lillicrap,et al.  Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. , 1999, Blood.

[27]  J. Greenberger,et al.  Two Repressor Elements Inhibit Expression of the von Willebrand Factor Gene Promoter In Vitro , 1998, Thrombosis and Haemostasis.

[28]  P. Foster,et al.  The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. , 1996, Blood.

[29]  K. Titani,et al.  Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. , 1992, The Journal of biological chemistry.

[30]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[31]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[32]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.

[33]  S. Latt,et al.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. , 1985, Science.

[34]  H. Akaike A new look at the statistical model identification , 1974 .